Intravenous Lidocaine in Children Undergoing Laparoscopic Appendectomy

• Status: Completed
• Trial end date: 2020-01-17
• Target enrollment: 0
• Participant gender: All

Summary

Intravenous lidocaine - a potent local anesthetic with analgesic and anti-inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study was planned to evaluate the efficacy of continuous intravenous infusion of lidocaine to reduce opioid consumption during and after laparoscopic appendectomy in children.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Warsaw
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

1. Age between 18 months and 18 year-old

2. Patients with American Society of Anaesthesiologists physical status (ASA) class 1/1E, 2/2E, 3/3E

3. Patients undergoing laparoscopic appendectomy

Exclusion Criteria:

1. Allergy to local anesthetics or contraindication to use of lidocaine

2. Patients with American Society of Anaesthesiologists physical status (ASA) IV or more.

3. Severe cardiovascular disease

4. Preoperative bradycardia

5. Preoperative atrioventricular block

6. Renal failure

7. Chronic treatment with analgesics

8. Parents' refusal